A “structured dialog” is urgently needed between industry, the European Commission, member states and regulators to “plan for a possible extended duration” of the coronavirus outbreak, according to off-patent industry association Medicines for Europe.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?